Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Nigel Saunders
    Junior Member
    • Apr 2011
    • 1

    #1

    How much rRNA sequence is reasonable in an RNA-seq dataset?

    Dear all,
    I have just received two RNA-seq datasets from a bacterial comparision. The reads are at least 50% (have not been able to look deeper yet) of 16 and 23S rRNA (i.e. all the top over-represented sequences by fastqc are rRNA). The centre that processed this insisted on doing the RNA depletion as part of their pipeline, and I believe used the Ribo-Zero (Epicentre) methodology which is supposed to be a good one.
    What percentage post depletion should I have typically expected? Is this normal, or have they failed to do the rRNA depletion properly?
    Nigel
  • Melissa
    Senior Member
    • Aug 2008
    • 124

    #2
    I think this topic has been discussed in the old thread. Back in the days when people are still using Invitrogen Ribominus kit, 30-40% rRNA in a RNA-Seq data is quite good. The new kits should perform better. In my own experience, percentage of rRNA in the data depends very much on the mapping parameters you use. I can map 30% if I allow 2 mismatch in 50bp reads but up to 50% if I use a min of 30bp extract matching. That's a huge difference.

    Comment

    • Lucilia
      Junior Member
      • Jul 2010
      • 6

      #3
      Originally posted by Melissa View Post
      I think this topic has been discussed in the old thread. Back in the days when people are still using Invitrogen Ribominus kit, 30-40% rRNA in a RNA-Seq data is quite good. The new kits should perform better. In my own experience, percentage of rRNA in the data depends very much on the mapping parameters you use. I can map 30% if I allow 2 mismatch in 50bp reads but up to 50% if I use a min of 30bp extract matching. That's a huge difference.
      Hi Mellissa
      I have a worse situation than Nigel. My sequencing results showed 86% of rRNA ( I have to check the parameters used). The service provider showed me the mRNA agilent profile and it indicated 11% of rRNA contamination (poly A purification). How did it become 86%? What percentage of ribosomal RNA contamination is acceptable in the purified mRNA for 454 sequencing?

      Comment

      • pmiguel
        Senior Member
        • Aug 2008
        • 2328

        #4
        Originally posted by Lucilia View Post
        Hi Mellissa
        I have a worse situation than Nigel. My sequencing results showed 86% of rRNA ( I have to check the parameters used). The service provider showed me the mRNA agilent profile and it indicated 11% of rRNA contamination (poly A purification). How did it become 86%? What percentage of ribosomal RNA contamination is acceptable in the purified mRNA for 454 sequencing?
        Probably you were shown an Agilent Bioanalyzer RNA Nano chip run in "mRNA" mode. The analysis must presume that the ribosomal RNA is still intact. If any degradation happened along the way (or was present initially) then rRNA starts to look like just plain old RNA. Hence, not an accurate measurement of the amount of rRNA in the polyA purified fraction.

        I don't think there is any standard as to what is "acceptable". Personally I have found that a single cycle of rRNA depletion does a poor job of removing all the rRNA. But yields from doing 2 cycles are terrible usually.

        The amount of polyA in your sample will be organism and tissue specific. And this probably plays an enormous role in amount of rRNA left after purification. Actually I mentioned in another thread (some years ago?) a paper where they posed the following thought experiment. Imagine a sample that is 95% rRNA. Say you have a protocol that will remove 90% of rRNA from a sample during a single cycle of depletion. You might naively expect only 10% rRNA to remain after one cycle. But this is mistaken.

        What you expect is that 90% of the rRNA is removed. What does that mean in real terms? Think of 100 RNA molecules -- 95 are rRNA and 5 are non-rRNA. 90% of 95 is about 86 molecules of rRNA molecules being removed. That leaves 9 (95-86) molecules of rRNA and the 5 non-rRNA molecules. So your sample is still 65% rRNA (9/16). That is the theoretical best case. So in cases where your polyA RNA makes up a very small fraction of the total RNA, either you do 2 cycles of depletion and your yields suck, or your do 1 cycle and sequence mostly ribosomal.

        --
        Phillip

        Comment

        • Lucilia
          Junior Member
          • Jul 2010
          • 6

          #5
          Originally posted by pmiguel View Post
          Probably you were shown an Agilent Bioanalyzer RNA Nano chip run in "mRNA" mode. The analysis must presume that the ribosomal RNA is still intact. If any degradation happened along the way (or was present initially) then rRNA starts to look like just plain old RNA. Hence, not an accurate measurement of the amount of rRNA in the polyA purified fraction.

          I don't think there is any standard as to what is "acceptable". Personally I have found that a single cycle of rRNA depletion does a poor job of removing all the rRNA. But yields from doing 2 cycles are terrible usually.

          The amount of polyA in your sample will be organism and tissue specific. And this probably plays an enormous role in amount of rRNA left after purification. Actually I mentioned in another thread (some years ago?) a paper where they posed the following thought experiment. Imagine a sample that is 95% rRNA. Say you have a protocol that will remove 90% of rRNA from a sample during a single cycle of depletion. You might naively expect only 10% rRNA to remain after one cycle. But this is mistaken.

          What you expect is that 90% of the rRNA is removed. What does that mean in real terms? Think of 100 RNA molecules -- 95 are rRNA and 5 are non-rRNA. 90% of 95 is about 86 molecules of rRNA molecules being removed. That leaves 9 (95-86) molecules of rRNA and the 5 non-rRNA molecules. So your sample is still 65% rRNA (9/16). That is the theoretical best case. So in cases where your polyA RNA makes up a very small fraction of the total RNA, either you do 2 cycles of depletion and your yields suck, or your do 1 cycle and sequence mostly ribosomal.

          --
          Phillip
          Hi Phillip, Thanks for the considerations.
          You are right! The profile is mRNA mode. I also checked the RIN number of the samples and it is bellow 8 (a number that I´ve read here would be indicated). The service provider assure that they purified twice and don´t know why the reason of the huge rRNA contamination in the results. Attached are the obtained profiles of total and mRNA - maybe someone has an insight of what is going on..
          The service provider would like to try ribominus (what would cost me more) and I´m in doubt if it would solve the problem....
          Attached Files

          Comment

          • pmiguel
            Senior Member
            • Aug 2008
            • 2328

            #6
            Well, the chips are pretty much useless for estimating rRNA % of a sample. All they show is the % of intact rRNA in the sample. If the rRNA degrades at any point, it will not be identifiable as such by the chip software.

            Obviously ribo-depletion was not successful for you samples.

            --
            Phillip

            Comment

            • Lucilia
              Junior Member
              • Jul 2010
              • 6

              #7
              So... That's what I' m thinking to do: purify more total RNA, considering the degradation problem, and perform another purification step ( invisorb) before mRNA isolation (I'm guessing that some impurities in the total RNA samples are disturbing the rRNA depletion). I hope it works...
              Lucilia

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
                by SEQadmin2



                Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

                Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
                ...
                10-14-2026, 09:55 AM
              • SEQadmin2
                New Genomics Technologies Take Aim at Long-Standing Limits
                by SEQadmin2


                Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

                We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
                ...
                09-28-2026, 10:25 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, 10-15-2026, 10:52 AM
              0 responses
              20 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 10-14-2026, 05:39 AM
              0 responses
              26 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 10-13-2026, 09:56 AM
              0 responses
              22 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 10-09-2026, 11:14 AM
              0 responses
              28 views
              0 reactions
              Last Post SEQadmin2  
              Working...